Skip to Main Content

Author Details

Sarah A Stanley
University of California berkeley
2001
48
26
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36988462MarR-Dependent Transcriptional Regulation of <i>mmpSL5</i> Induces Ethionamide Resistance in Mycobacterium abscessus.Antimicrob Agents Chemother2023
37662190Disruption of Aldehyde Dehydrogenase 2 protects against bacterial infection.bioRxiv2023
37609245Mycobacterial formation of intracellular lipid inclusions is a dynamic process associated with rapid replication.bioRxiv2023
34965963Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against <i>Mycobacterium tuberculosis</i> Infection.J Immunol2022
35589813Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro.Nat Commun2022
35414258The aldehyde hypothesis: metabolic intermediates as antimicrobial effectors.Open Biol2022
36494335SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling.Nat Commun2022
36327900The sympathetic nervous system in the 21st century: Neuroimmune interactions in metabolic homeostasis and obesity.Neuron2022
35922434An intranasal ASO therapeutic targeting SARS-CoV-2.Nat Commun2022
36323770Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells.Sci Rep2022
36287912SARS-CoV-2 down-regulates ACE2 through lysosomal degradation.Mol Biol Cell2022
35879412Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.Nat Genet2022
35143587The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.PLoS Pathog2022
34129317Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.ACS Infect Dis2021
33534838Open-source RNA extraction and RT-qPCR methods for SARS-CoV-2 detection.PLoS One2021
33637017The Innate Immune Response to <i>Mycobacterium tuberculosis</i> Infection.Annu Rev Immunol2021
34645859Mapping of UV-C dose and SARS-CoV-2 viral inactivation across N95 respirators during decontamination.Sci Rep2021
34637475Practical considerations for Ultraviolet-C radiation mediated decontamination of N95 respirator against SARS-CoV-2 virus.PLoS One2021
34462750The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.bioRxiv2021
34634033SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA.PLoS Biol2021
34751132A nanocompartment system contributes to defense against oxidative stress in <i>Mycobacterium tuberculosis</i>.Elife2021
31229914HIF-1α as a central mediator of cellular resistance to intracellular pathogens.Curr Opin Immunol2019
29370315Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense.PLoS Pathog2018
29719256STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection.Cell Rep2018
28537707The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.ACS Infect Dis2017
28754681Nitric Oxide Modulates Macrophage Responses to <i>Mycobacterium tuberculosis</i> Infection through Activation of HIF-1α and Repression of NF-κB.J Immunol2017
27430718HIF-1α Is an Essential Mediator of IFN-γ-Dependent Immunity to Mycobacterium tuberculosis.J Immunol2016
24586159Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth.PLoS Pathog2014
23798446Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32.Proc Natl Acad Sci U S A2013
24103299Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.Bioorg Med Chem Lett2013
23881288Host-pathogen interactions during Mycobacterium tuberculosis infections.Curr Top Microbiol Immunol2013
23898841Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model.ACS Chem Biol2013
22086462Systematics-guided bioprospecting for bioactive microbial natural products.Antonie Van Leeuwenhoek2012
22913407The first synthesis of an epidiselenodiketopiperazine.Org Lett2012
22474362RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities.Proc Natl Acad Sci U S A2012
22577943Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening.ACS Chem Biol2012
22292986MetaMerge: scaling up genome-scale metabolic reconstructions with application to Mycobacterium tuberculosis.Genome Biol2012
19653697Chemical tools for dissecting bacterial physiology and virulence.Biochemistry2009
20371455Toward a systems-level analysis of infection biology: a new method for conducting genetic screens in human cells.Sci Transl Med2009
17420014Nippostrongylus brasiliensis: identification of intelectin-1 and -2 as Stat6-dependent genes expressed in lung and intestine during infection.Exp Parasitol2007
17312162The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis.J Immunol2007
16973880C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis.Science2006
16135231A non-RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis.Mol Microbiol2005
14662870Basal chromatin modification at the IL-4 gene in helper T cells.J Immunol2003
12934078Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL.Cell Death Differ2003
12902482T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response.J Immunol2003
14557536Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system.Proc Natl Acad Sci U S A2003
11698434Inefficient ZAP-70 phosphorylation and decreased thymic selection in vivo result from inhibition of NF-kappaB/Rel.J Immunol2001
  • 1 - 48 of 48

Recommended Authors

Bryan D Bryson
Massachusetts Institute of Technology, USA The Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 3
Matthew F Wipperman
Regeneron Pharmaceuticals, Inc.
Career Start Year 2012
Number of shared co-authors 2
Eusondia Arnett
Texas Biomedical Research Institute
Career Start Year 2011
Number of shared co-authors 1
Samantha L Bell
College of Medicine, Rutgers New Jersey Medical School
Career Start Year 2009
Number of shared co-authors 5
Andrew J Olive
College of Osteopathic Medicine, Michigan State University
Career Start Year 2006
Number of shared co-authors 4
Bree B Aldridge
Tufts University School of Engineering
Career Start Year 2006
Number of shared co-authors 1
Jinhee Lee
University of Massachusetts Medical School
Career Start Year 2005
Number of shared co-authors 0
Jeremy M Rock
The Rockefeller University
Career Start Year 2005
Number of shared co-authors 2
Dhiraj Kumar
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Chih-Yuan Chiang
United States Army Medical Research Institute of Infectious Diseases
Career Start Year 2003
Number of shared co-authors 0
Kristine M Guinn
Harvard T. H. Chan School of Public Health
Career Start Year 2003
Number of shared co-authors 0
Alan H Diercks
Seattle Children's Research Institute
Career Start Year 2002
Number of shared co-authors 1
Kristin L Patrick
Texas A&M University School of Medicine
Career Start Year 2001
Number of shared co-authors 2
Robert O Watson
Texas A&M University School of Medicine
Career Start Year 2001
Number of shared co-authors 2
Antje Blumenthal
Frazer Institute, The University of Queensland
Career Start Year 2001
Number of shared co-authors 0
Carrie M Rosenberger
Genentech Inc.
Career Start Year 2000
Number of shared co-authors 2
Reto Guler
International Centre for Genetic Engineering and Biotechnology
Career Start Year 1999
Number of shared co-authors 0
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 1
Michael S Glickman
Memorial Sloan Kettering Cancer Center
Career Start Year 1997
Number of shared co-authors 3
Paul de Figueiredo
Texas A&M University, College Station
Career Start Year 1995
Number of shared co-authors 2
Rodrigo Andres Floto
University of Cambridge
Career Start Year 1995
Number of shared co-authors 1
Marianna Orlova
The Research Institute of the McGill University Health Centre
Career Start Year 1994
Number of shared co-authors 0
Mahdad Noursadeghi
University College London
Career Start Year 1992
Number of shared co-authors 1
Victor Nizet
university of california san diego School of Medicine
Career Start Year 1991
Number of shared co-authors 0
David R Sherman
University of Washington
Career Start Year 1987
Number of shared co-authors 2
Joel D Ernst
University of California san francisco
Career Start Year 1986
Number of shared co-authors 3
Larry S Schlesinger
Texas Biomedical Research Institute
Career Start Year 1984
Number of shared co-authors 1
Hardy Kornfeld
University of Massachusetts Chan Medical School
Career Start Year 1982
Number of shared co-authors 0
Maria Laura Gennaro
Public Health Research Institute, Rutgers New Jersey Medical School
Career Start Year 1980
Number of shared co-authors 0
Alan Aderem
Seattle Children's Research Institute
Career Start Year 1979
Number of shared co-authors 1

Collaborators

Erik Van Dis
University of California berkeley
Co-authored papers 8
Jeffery S Cox
University of California berkeley
Co-authored papers 7
Julia Schaletzky
Center for Emerging and Neglected Diseases, University of California Berkeley
Co-authored papers 5
Kimberly M Sogi
School of Public Health, University of California berkeley
Co-authored papers 4
Guillaume Golovkine
University of California berkeley
Co-authored papers 3
Melanie R Silvis
University of California - San Francisco
Co-authored papers 3
Allison W Roberts
University of California berkeley
Co-authored papers 3
Daniel K Nomura
University of California berkeley
Co-authored papers 2
Ralph S Baric
University of North Carolina
Co-authored papers 2
Hector C Aguilar
Co-authored papers 2
Katie A Lien
Pritzker School of Medicine, University of Chicago
Co-authored papers 2
Charles Y Chiu
University of California-San Francisco
Co-authored papers 2
Mark-Anthony Bray
Co-authored papers 1
Andreas S Puschnik
Stanford University School of Medicine
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Xueqiu Lin
Co-authored papers 1
Rodney C Gilmore
Co-authored papers 1
Bonnie Berger
Massachusetts Institute of Technology
Co-authored papers 1
Robert J Nichols
Stanford University
Co-authored papers 1
Carolyn R Bertozzi
Stanford University
Co-authored papers 1
Daniel A Portnoy
University of California berkeley
Co-authored papers 1
Nir Yosef
Center for Computational Biology, University of California berkeley
Co-authored papers 1
Thomas R Ioerger
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Jan E Carette
Stanford University School of Medicine
Co-authored papers 1
Sarah R Leist
University of North Carolina at Chapel Hill
Co-authored papers 1
Matthew M Champion
Co-authored papers 1
Kevin Holden
Synthego Corporation
Co-authored papers 1
Brian Button
Co-authored papers 1
David F Savage
University of California berkeley
Co-authored papers 1
Release 1.2